We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$74.4M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$42.5M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$24.2M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$17.4M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$12.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$105M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.8M
4
MSFT icon
Microsoft
MSFT
+$12.8M
5
AAPL icon
Apple
AAPL
+$11.9M

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSKE
2801
DELISTED
Daseke, Inc. Common Stock
DSKE
$7K ﹤0.01%
1,865
-4,820
-72% -$22.8K
KDNY
2802
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$7K ﹤0.01%
888
-744
-46% -$11.3K
FCRD
2803
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$7K ﹤0.01%
1,108
-8,053
-88% -$53.8K
CFMS
2804
DELISTED
Conformis, Inc. Common Stock
CFMS
$7K ﹤0.01%
+60
New +$4.94K
QTNT
2805
DELISTED
Quotient Limited Ordinary Shares
QTNT
$7K ﹤0.01%
18
-14
-44% -$5K
NBEV
2806
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$7K ﹤0.01%
+1,599
New +$8.19K
SQBG
2807
DELISTED
Sequential Brands Group, Inc.
SQBG
$7K ﹤0.01%
+315
New +$10.6K
HOME
2808
DELISTED
At Home Group Inc.
HOME
$7K ﹤0.01%
+969
New +$17.2K
UROV
2809
DELISTED
Urovant Sciences Ltd.
UROV
$7K ﹤0.01%
914
-440
-32% -$3.61K
NEOS
2810
DELISTED
Neos Therapeutics, Inc
NEOS
$7K ﹤0.01%
5,500
-2,435
-31% -$4.48K
AIZP
2811
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
$7K ﹤0.01%
+59
New +$6.29K
BFYT
2812
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$7K ﹤0.01%
283
-5,985
-95% -$150K
IPHS
2813
DELISTED
Innophos Holdings, Inc.
IPHS
$7K ﹤0.01%
242
-79
-25% -$2.36K
BOLD
2814
DELISTED
Audentes Therapeutics, Inc
BOLD
$7K ﹤0.01%
+197
New +$7.57K
CRAY
2815
DELISTED
Cray, Inc.
CRAY
$7K ﹤0.01%
211
-1,047
-83% -$32.4K
MNTX
2816
DELISTED
Manitex International, Inc.
MNTX
$7K ﹤0.01%
1,143
+671
+142% +$4.58K
BKSC
2817
DELISTED
Bank of South Carolina
BKSC
$7K ﹤0.01%
+366
New +$6.81K
AUO
2818
DELISTED
AU Optronics Corp
AUO
$7K ﹤0.01%
2,210
-6,094
-73% -$19.7K
GCI
2819
DELISTED
Gannett Co., Inc
GCI
$7K ﹤0.01%
880
-5,582
-86% -$49.7K
AGNC icon
2820
AGNC Investment
AGNC
$12.9B
$6K ﹤0.01%
381
-31,101
-99% -$541K
AMWD
2821
DELISTED
American Woodmark
AMWD
$6K ﹤0.01%
+65
New +$5.48K
ANGL icon
2822
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.06B
$6K ﹤0.01%
200
– –
ATOS icon
2823
Atossa Therapeutics
ATOS
$23.5M
$6K ﹤0.01%
+150
New +$6.01K
ATXS
2824
DELISTED
Astria Therapeutics
ATXS
$6K ﹤0.01%
118
+101
+594% +$4.58K
DCH
2825
Dauch Corp
DCH
$1.51B
$6K ﹤0.01%
449
-4,445
-91% -$57.9K
111 112
113
114 115

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.